ARMP
AMEX · Biotechnology
Armata Pharmaceuticals Inc
$6.48
+0.02 (+0.31%)
Open$6.43
Previous Close$6.46
Day High$6.67
Day Low$6.35
52W High$16.34
52W Low$1.91
Volume—
Avg Volume302.3K
Market Cap216.23M
P/E Ratio—
EPS$-7.76
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+169.3% upside
Current
$6.48
$6.48
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.51M | 4.69M | 51.72M |
| Net Income | -160,031,078 | -149,732,789 | -16,237,176 |
| Profit Margin | -3,544.0% | -3,366.8% | -31.4% |
| EBITDA | -32,320,545 | -31,920,696 | -19,844,642 |
| Free Cash Flow | — | — | -12,228,215 |
| Rev Growth | -3.8% | -3.8% | -2.8% |
| Debt/Equity | — | — | 1.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |